M
Michael C. Rowbotham
Researcher at University of California, San Francisco
Publications - 161
Citations - 19307
Michael C. Rowbotham is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Neuropathic pain & Chronic pain. The author has an hindex of 58, co-authored 156 publications receiving 17465 citations. Previous affiliations of Michael C. Rowbotham include Sutter Health & University of San Francisco.
Papers
More filters
Journal ArticleDOI
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B. Finnerup,Nadine Attal,Simon Haroutounian,Ewan D McNicol,Ralf Baron,Robert H. Dworkin,Ian Gilron,Maija Haanpää,Per Hansson,Per Hansson,Troels S. Jensen,Troels S. Jensen,Peter R. Kamerman,Karen Lund,Andrew Moore,Srinivasa N. Raja,Andrew S.C. Rice,Andrew S.C. Rice,Michael C. Rowbotham,Emily S. Sena,Emily S. Sena,Philip J. Siddall,Philip J. Siddall,Blair H. Smith,Mark S. Wallace +24 more
TL;DR: The results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain and allow a strong recommendation for use and proposal as first-line treatment in neuropathicPain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin.
Journal ArticleDOI
Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
TL;DR: Gabapentin is effective in the treatment of pain and sleep interference associated with PHN and Mood and quality of life also improve with gabapentin therapy.
Journal ArticleDOI
Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations
Robert H. Dworkin,Miroslav Backonja,Michael C. Rowbotham,Robert R. Allen,Charles R. Argoff,Gary J. Bennett,M. Catherine Bushnell,John T. Farrar,Bradley S. Galer,Jennifer A. Haythornthwaite,David J. Hewitt,John D. Loeser,Mitchell B. Max,Mario Saltarelli,Kenneth E. Schmader,Christoph Stein,David R. Thompson,Dennis C. Turk,Mark S. Wallace,Linda R. Watkins,Sharon M. Weinstein +20 more
TL;DR: In this article, the authors describe current approaches to the diagnosis and assessment of neuropathic pain and discuss the results of recent research on its pathophysiologic mechanisms, and provide specific recommendations for use of these medications.
Journal ArticleDOI
NeuPSIG guidelines on neuropathic pain assessment
Maija Haanpää,Nadine Attal,Miroslav Backonja,Ralf Baron,Michael I. Bennett,Didier Bouhassira,Giorgio Cruccu,Per Hansson,Jennifer A. Haythornthwaite,Gian Domenico Iannetti,Troels S. Jensen,Timo Kauppila,Turo Nurmikko,Andew S C Rice,Michael C. Rowbotham,Jordi Serra,Claudia Sommer,Blair H. Smith,Rolf-Detlef Treede +18 more
TL;DR: Screening questionnaires are suitable for identifying potential patients with neuropathic pain, but further validation of them is needed for epidemiological purposes and quantitative sensory testing is recommended for selected cases in clinic, including the diagnosis of small fiber neuropathies and for research purposes.
Journal ArticleDOI
Recommendations for the management of herpes zoster.
Robert H. Dworkin,Robert W. Johnson,Judith Breuer,John W. Gnann,John W. Gnann,Myron J. Levin,Miroslav Backonja,Robert F. Betts,Anne A. Gershon,Maija Haanpää,M.W. McKendrick,Turo Nurmikko,Anne Louise Oaklander,Michael N. Oxman,Deborah Pavan-Langston,Karin L. Petersen,Michael C. Rowbotham,Kenneth E. Schmader,Brett R. Stacey,Stephen K. Tyring,Albert J.M. van Wijck,Mark S. Wallace,Sawko W. Wassilew,Richard J. Whitley +23 more
TL;DR: The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacy Clovir as first-line antiviral therapy for the treatment of patients with HZ.